QUTENZA
Peakcapsaicin
NDATOPICALPATCH
Approved
Nov 2009
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
19
Clinical Trials (5)
Comparison of the Bioavailability of Diclofenac in a Combination Product (Diclofenac 2% + Capsaicin 0.075% Topical Gel) With Two Diclofenac Only Products, Diclofenac Mono Gel 2% and Voltarol® 12 Hour Emulgel 2.32% Gel, in Healthy Volunteers
Started Apr 2017
48 enrolled
Healthy
Capsaicin + Diclofenac Gel in Acute Back Pain or Neck Pain
Started May 2016
746 enrolled
Acute Pain
Pain Thresholds Under High-dose Topical Capsaicin
Started Feb 2015
20 enrolled
Pain
A Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic Pain
Started Jan 2014
319 enrolled
Post-operative Peripheral Neuropathic Pain
Effect Of PF-06305591 On Capsaicin And Capsaicin/Heat-Induced Neurogenic Flare
Started Apr 2013
16 enrolled
Healthy
Loss of Exclusivity
LOE Date
Mar 26, 2030
49 months away
Patent Expiry
Mar 26, 2030